IL13 and asthma: In contrast, in a 17-centre prospective cohort study of infants with severe bronchiolitis, serum periostin induced by type 2 inflammatory cytokines (e.g., interleukin IL-4 and IL-13) was associated with asthma risk by age 6 years (37).